Scanlan Sean F. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Award
Common Stock
2025-01-22+140,625→ 365,878 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]Includes 332,473 restricted stock units.